RIBONUCLEASE SUPERFAMILY--STRUCTURE-FUNCTION STUDIES

核糖核酸酶超家族——结构-功能研究

基本信息

  • 批准号:
    3309159
  • 负责人:
  • 金额:
    $ 20.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-08-01 至 1996-07-31
  • 项目状态:
    已结题

项目摘要

This project is concerned with obtaining detailed structure-function correlations for members of the ribonuclease superfamily. This family of proteins includes digestive enzymes such bovine pancreatic ribonuclease (RNase A), toxins, such as human eosinophil derived neurotoxin, growth factors such as human angiogenin, and P-30, a protein with significant toxicity against human tumor cell lines. The sequence homology and ribonucleolytic activity of all these proteins, suggests that they share a common catalytic mechanism and tertiary structure. The vast amount of structural and biochemical information available for RNase A provides a unique opportunity to examine the basis for the biological activities displayed by members of the ribonuclease superfamily. RNase A will be systematically mutated towards the primary sequence of these homologs, and the hybrid proteins will be examined by X-ray crystallography, kinetics and the appropriate bioassays. In every case, the biological activities have been linked to the ribonucleolytic activity. It is therefore crucial to understand the detailed enzymatic mechanism(s) used by the various homologs. In addition to unraveling the connection between enzymatic activity and biological function, the production of hybrid proteins will allow for the study of phenomena which are of fundamental importance to enzymology. Specifically, members of the ribonuclease superfamily utilize the binding energy of extended substrates to enhance catalytic efficiency by up to four orders of magnitude. Furthermore, the rate of catalysis in the superfamily is highly sensitive to the identity of amino acids which are not directly involved in either the chemical transformation or substrate binding: kcat/Km spans six orders of magnitude across the superfamily. How enzymatic activity is effected by interactions distant from the site of chemistry is one of the outstanding questions in enzymology, and is of general importance. The production of hybrid ribonucleases will allow for an examination of important biological activities such as neurotoxicity, growth factor activity and tumor cytotoxicity. In addition, these same studies will address the fundamental question of 'long range distant effects' in catalysis. Defining the structural and chemical determinants responsible for these biological activities will be instrumental in understanding their underlying mechanism and in providing a basis for therapeutic development.
本项目致力于获取详细的结构功能 核糖核酸酶超家族成员的相关性。这个家庭 包括消化酶,如牛胰腺 核糖核酸酶(RNaseA),毒素,如人类嗜酸性粒细胞来源 神经毒素,人血管生成素等生长因子,以及蛋白质P-30 对人肿瘤细胞系有显著毒性。该序列 所有这些蛋白质的同源性和核糖核溶解活性 它们具有共同的催化机理和三级结构。这个 核糖核酸酶的大量结构和生化信息 A提供了一个独特的机会来检查生物学的基础 核糖核酸酶超家族成员所展示的活动。核酸酶 A将被系统地突变为这些基因的初级序列 同源物,杂交蛋白将通过X射线进行检查 结晶学、动力学和适当的生物测定。 在每一种情况下,生物活动都与 核糖核溶解活性。因此,理解 详细的酶作用机理(S)所用的各种同源物。在……里面 除了解开酶活性和 生物学功能,杂交蛋白的生产将允许 对酶学有重要意义的现象的研究。 具体地说,核糖核酸酶超家族的成员利用结合 延长底物的能量,以提高催化效率高达 四个数量级。此外,催化反应的速度 超家族对氨基酸的特性高度敏感,这些氨基酸是 不直接参与化学转化或底物 绑定:kcat/kM跨越超家族的六个数量级。 远离位点的相互作用如何影响酶的活性 化学是酶学研究中的一个突出问题,也是 具有普遍重要性。 杂交核糖核酸酶的生产将允许对 重要的生物活性,如神经毒性、生长因子 活性和肿瘤细胞毒性。此外,这些相同的研究将 解决了“远距离效应”的根本问题 催化作用。确定负责的结构和化学决定因素 因为这些生物活动将有助于理解 它们的潜在机制并为治疗提供了基础 发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN C. ALMO其他文献

STEVEN C. ALMO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN C. ALMO', 18)}}的其他基金

Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
扩增和重定向 CMV 特异性 CD8 T 细胞以持续控制 HIV 感染
  • 批准号:
    10834306
  • 财政年份:
    2022
  • 资助金额:
    $ 20.14万
  • 项目类别:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
扩增和重定向 CMV 特异性 CD8 T 细胞以持续控制 HIV 感染
  • 批准号:
    10548600
  • 财政年份:
    2022
  • 资助金额:
    $ 20.14万
  • 项目类别:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
扩增和重定向 CMV 特异性 CD8 T 细胞以持续控制 HIV 感染
  • 批准号:
    10807389
  • 财政年份:
    2022
  • 资助金额:
    $ 20.14万
  • 项目类别:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
扩增和重定向 CMV 特异性 CD8 T 细胞以持续控制 HIV 感染
  • 批准号:
    10634689
  • 财政年份:
    2022
  • 资助金额:
    $ 20.14万
  • 项目类别:
Cancer Therapuetics
癌症治疗学
  • 批准号:
    10429332
  • 财政年份:
    2021
  • 资助金额:
    $ 20.14万
  • 项目类别:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
旨在调动 HIV 特异性 CTL 以实现持续 HIV 缓解的新型生物制剂
  • 批准号:
    9752177
  • 财政年份:
    2019
  • 资助金额:
    $ 20.14万
  • 项目类别:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
旨在调动 HIV 特异性 CTL 以实现持续 HIV 缓解的新型生物制剂
  • 批准号:
    10596609
  • 财政年份:
    2019
  • 资助金额:
    $ 20.14万
  • 项目类别:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
旨在调动 HIV 特异性 CTL 以实现持续 HIV 缓解的新型生物制剂
  • 批准号:
    9908044
  • 财政年份:
    2019
  • 资助金额:
    $ 20.14万
  • 项目类别:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
旨在调动 HIV 特异性 CTL 以实现持续 HIV 缓解的新型生物制剂
  • 批准号:
    10375382
  • 财政年份:
    2019
  • 资助金额:
    $ 20.14万
  • 项目类别:
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells
自身反应性 CD8 T 细胞的结构、功能和机制分析
  • 批准号:
    10335165
  • 财政年份:
    2018
  • 资助金额:
    $ 20.14万
  • 项目类别:

相似海外基金

Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334970
  • 财政年份:
    2024
  • 资助金额:
    $ 20.14万
  • 项目类别:
    Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
  • 批准号:
    2400195
  • 财政年份:
    2024
  • 资助金额:
    $ 20.14万
  • 项目类别:
    Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334969
  • 财政年份:
    2024
  • 资助金额:
    $ 20.14万
  • 项目类别:
    Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
  • 批准号:
    23K04919
  • 财政年份:
    2023
  • 资助金额:
    $ 20.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
  • 批准号:
    22KJ2957
  • 财政年份:
    2023
  • 资助金额:
    $ 20.14万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
  • 批准号:
    23K04494
  • 财政年份:
    2023
  • 资助金额:
    $ 20.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
  • 批准号:
    23K13831
  • 财政年份:
    2023
  • 资助金额:
    $ 20.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
  • 批准号:
    2238379
  • 财政年份:
    2023
  • 资助金额:
    $ 20.14万
  • 项目类别:
    Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
  • 批准号:
    2154399
  • 财政年份:
    2022
  • 资助金额:
    $ 20.14万
  • 项目类别:
    Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
  • 批准号:
    RGPIN-2019-06633
  • 财政年份:
    2022
  • 资助金额:
    $ 20.14万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了